Neurotechnology company Cognito Therapeutics scores $73M
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
From the blog of Lili Eylon at The Times of Israel
Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatmentÂ
23.02.2023 - The company has now been awarded a total of eight FDA Breakthrough Device Designations for its innovative SCI therapiesEINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023 (GLOBE NEWSWIRE) - ONWARD Medical N.V. ... Seite 1
The company has now been awarded a total of eight FDA Breakthrough Device Designations for its innovative SCI therapiesEINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, Feb. 23, 2023